Minimally Access versus Conventional Hydrocelectomy:A Randomized Trial

Not Applicable

Completed

• Conditions: Primary hydrocele; Surgery - Surgical techniques

• Registration Number: ACTRN12613001227785
• Lead Sponsor: Aly Saber

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-11-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

Male patients with primary non recurrent vaginal hydroceles.

Exclusion Criteria

patients with secondary or recurrent vaginal hydroceles.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary end point of the study is recurrence , defined as a clinically detectable characteristic swelling in the scrotum and diagnosed by the author.[From the 1st week of surgery until the end of the follow up period of 60 months.]

Secondary Outcome Measures

Name	Time	Method
Postoperative hematoma, assessed clinically by the treating surgeon.[Monitored on a 6 hourly basis immediately after surgery until the end of the 3rd postoperative day.];Persistent scrotal edema and hardening, assessed clinically by the treating surgeon. [Monitored on a daily basis from the 2nd postoperative day until the end of the 3rd postoperative week.];Wound sepsis, assessed clinically by the treating surgeon. [Monitored on a daily basis from the 3rd postoperative day until the end of the 3rd postoperative week.]